Dr Peter Lassoff Pharm.D., FTOPRA, has over 30 years’ experience within global regulatory affairs and most recently ran the Regulatory Affairs division of IQVIA (Quintiles) as VP and Head of Global Regulatory Affairs. Peter has deep domain expertise in regulatory affairs and drug development, and has established and grown businesses in the regulatory outsourcing sector on a global basis.
Peter joined IQVIA in 2011 after many years in senior regulatory posts within the pharmaceutical and CRO industries. He is an American with a Pharm.D. from the University of Southern California School of Pharmacy, and has worked in the UK for BMS and for the research division of Stiefel Laboratories. Within BMS, he worked for the pharmaceutical division and for ConvaTec, their medical devices subsidiary. More recently, Peter worked for Parexel where he ran their European regulatory group. He has experience within a global R&D headquarters, with project leadership and management roles. Peter provides experience and expertise in the development and worldwide registration of dermatological products, ‘borderline’ products, medical devices, cosmetics and ‘cosmeceuticals’, nutritional supplements and other regulated health-care products. Peter evaluates technologies or companies for acquisition with respect to cost of bringing the products to market, likelihood of registration, and costs involved with updating or optimising dossiers for worldwide registration.
Peter is a Fellow of TOPRA; is on the Board of Supervisors for the University of Southern California's regulatory affairs programme; and has won a lifetime achievement award for regulatory affairs from the USC School of Pharmacy.